Clinical profile, yield of cartridge-based nucleic acid amplification test (GeneXpert), and outcome in children with tubercular meningitis
Conclusion: GeneXpert has high diagnostic specificity, but negative results do not rule out TBM. CSF GeneXpert provided quick results. Placement of Ommaya reservoir in TBM stage II and III with hydrocephalus was not successful. Hydrocephalus was managed conservatively with success (53%).
Source: Journal of Pediatric Neurosciences - Category: Neuroscience Authors: Santosh K Soma Lokesh Lingappa Subodh Raju Ramesh Konanki Amit K Gaur Ashwini Mohan Smilu Mohanlal Source Type: research
More News: Brain | Carisoprodol | Children | Dystonia | Headache | Hydrocephalus | Learning | Men | Meningitis | Meningitis Vaccine | Migraine | Neurology | Neuroscience | Neurosurgery | Pediatrics | Research | Shunt for Hydrocephalus | Soma | Study | Tuberculosis | UK Health | Universities & Medical Training | Vaccines